Neuroendocrine tumor: Types, symptoms, causes, treatments

A neuroendocrine tumor, often shortened to NET, is one of those medical terms that sounds like it wandered out of a sci-fi movie wearing a lab coat. In reality, it refers to a real group of tumors that start in neuroendocrine cellsspecialized cells that behave a little like nerve cells and a little like hormone-producing endocrine cells. In other words, they are the body’s tiny message managers. When those cells grow abnormally, they can form tumors that may be slow-growing, aggressive, hormone-producing, silent, sneaky, or occasionally all of the above.

Neuroendocrine tumors can appear in many areas of the body, but they are most often found in the gastrointestinal tract, pancreas, lungs, appendix, rectum, and small intestine. Some NETs release hormones and cause noticeable symptoms such as flushing, diarrhea, wheezing, blood sugar swings, or stomach ulcers. Others do not produce obvious hormone symptoms and may stay hidden until imaging, surgery, or testing for another issue reveals them. This is why NETs are sometimes called “zebras” in medicine: uncommon, often overlooked, and not exactly interested in following the usual horse-shaped rules.

The good news is that many neuroendocrine tumors are treatable, especially when found early. Treatment has also improved significantly, with options that may include surgery, active surveillance, somatostatin analog medications, targeted therapy, peptide receptor radionuclide therapy, chemotherapy, radiation, liver-directed treatments, and symptom-control strategies. The best treatment depends on the tumor’s location, grade, stage, hormone activity, and whether it has spread.

What Is a Neuroendocrine Tumor?

A neuroendocrine tumor is a growth that begins in neuroendocrine cells. These cells are found throughout the body and help regulate functions by releasing hormones in response to signals from the nervous system. Because neuroendocrine cells are widely distributed, NETs can develop in many organs rather than being limited to one body system.

Not all neuroendocrine tumors behave the same way. Some grow slowly over many years, while others are high-grade and fast-moving. Some are functional, meaning they release enough hormones to cause symptoms. Others are nonfunctional, meaning they either do not release hormones or do not release enough to create obvious signs. This difference matters because a small functional tumor may create loud symptoms, while a larger nonfunctional tumor may remain quiet until it presses on nearby tissue.

Types of Neuroendocrine Tumors

Doctors classify neuroendocrine tumors in several ways: where they start, whether they produce hormones, how fast they grow, and what the cells look like under a microscope. Understanding the type helps guide treatment and gives patients a clearer picture of what to expect.

Gastrointestinal Neuroendocrine Tumors

Gastrointestinal NETs develop in the digestive tract, including the stomach, small intestine, appendix, colon, or rectum. Older terms such as “carcinoid tumor” are still sometimes used, especially for certain slow-growing digestive or lung NETs, but many specialists now prefer the more accurate term neuroendocrine tumor.

Symptoms may include abdominal pain, changes in bowel habits, nausea, vomiting, intestinal blockage, rectal bleeding, anemia, unexplained weight loss, or diarrhea. Some GI NETs produce serotonin or other substances that can lead to carcinoid syndrome, especially if the disease has spread to the liver.

Pancreatic Neuroendocrine Tumors

Pancreatic neuroendocrine tumors, also called pancreatic NETs or islet cell tumors, begin in the hormone-producing cells of the pancreas. They are different from the more common pancreatic adenocarcinoma, which starts in the ducts of the pancreas and usually behaves more aggressively.

Pancreatic NETs may be functional or nonfunctional. Functional pancreatic NETs can produce specific hormones and cause distinct syndromes. For example, insulinomas may cause low blood sugar, gastrinomas may cause severe ulcers and acid-related symptoms, and glucagonomas may cause rash, diabetes-like symptoms, and weight loss. Nonfunctional pancreatic NETs may cause vague symptoms such as abdominal or back pain, indigestion, jaundice, or weight loss after the tumor grows large enough to affect nearby structures.

Lung Neuroendocrine Tumors

Lung NETs begin in neuroendocrine cells in the lungs. They may be typical carcinoids, atypical carcinoids, large-cell neuroendocrine carcinomas, or small-cell lung cancers. Typical carcinoids tend to grow more slowly, while high-grade neuroendocrine carcinomas are more aggressive.

Symptoms can include a persistent cough, coughing up blood, wheezing, shortness of breath, chest pain, or repeated pneumonia in the same area of the lung. Some lung NETs are found after a chest scan done for another reason, which is the medical version of opening the junk drawer and discovering a tiny mystery with paperwork attached.

Appendiceal Neuroendocrine Tumors

Appendiceal NETs are often discovered unexpectedly after surgery for suspected appendicitis. Many are small and treated successfully with surgery, but management depends on tumor size, grade, margins, lymph node involvement, and other risk factors.

High-Grade Neuroendocrine Carcinomas

High-grade neuroendocrine carcinomas grow and spread faster than well-differentiated NETs. They may occur in the lung, gastrointestinal tract, pancreas, prostate, or other organs. These cancers often require more aggressive treatment, commonly including chemotherapy and sometimes radiation or clinical trials.

Common Symptoms of Neuroendocrine Tumors

Neuroendocrine tumor symptoms vary widely because NETs can form in different organs and may or may not release hormones. Some people have no symptoms for years. Others experience symptoms that seem unrelated, which can make diagnosis frustrating.

General Symptoms

General symptoms may include fatigue, unexplained weight loss, loss of appetite, pain in a specific area, a growing lump or mass, nausea, vomiting, bowel changes, bleeding, or anemia. These symptoms are not unique to NETs, which is why doctors usually consider many possible causes before reaching a diagnosis.

Hormone-Related Symptoms

Functional NETs can release hormones or hormone-like substances that trigger symptoms throughout the body. Possible signs include flushing of the face or neck, diarrhea, wheezing, rapid heartbeat, dizziness, sweating, anxiety-like episodes, confusion, skin rash, blood sugar changes, severe stomach ulcers, or persistent acid reflux.

Carcinoid Syndrome

Carcinoid syndrome happens when certain NETs release substances such as serotonin into the bloodstream. It is more common when tumors have spread to the liver, because the liver may no longer fully break down those substances before they circulate through the body.

Symptoms may include flushing, chronic diarrhea, wheezing, abdominal cramps, and rapid heartbeat. Over time, carcinoid syndrome can sometimes affect the heart valves, so doctors may monitor heart function in patients with ongoing hormone symptoms.

What Causes Neuroendocrine Tumors?

For most people, the exact cause of a neuroendocrine tumor is unknown. NETs begin when neuroendocrine cells develop DNA changes that allow them to grow and divide abnormally. These changes may happen by chance, may be linked to inherited syndromes, or may involve factors researchers are still studying.

Known risk factors include certain inherited conditions such as multiple endocrine neoplasia type 1, von Hippel-Lindau disease, neurofibromatosis type 1, and tuberous sclerosis. Family history can play a role in some cases. Age may also matter, as many NETs are diagnosed in adults rather than children, although pediatric cases do occur. Some stomach conditions may increase the risk of certain gastrointestinal NETs.

Having a risk factor does not mean a person will develop a NET, and many people diagnosed with neuroendocrine tumors have no clear risk factor at all. Cancer, unfortunately, does not always fill out a convenient permission slip before arriving.

How Neuroendocrine Tumors Are Diagnosed

Diagnosis often requires a combination of medical history, physical exam, blood and urine tests, imaging, and biopsy. Because NET symptoms can mimic more common conditions such as irritable bowel syndrome, asthma, menopause, ulcers, anxiety, or food intolerance, diagnosis may take time.

Blood and Urine Tests

Blood and urine tests may help detect hormone activity or substances associated with NETs. For example, doctors may measure 5-HIAA in urine when carcinoid syndrome is suspected. Other tests may evaluate insulin, gastrin, glucagon, chromogranin A, or additional markers depending on the symptoms and suspected tumor type.

These tests can support the diagnosis and help monitor treatment, but they usually cannot confirm NET by themselves. A tissue diagnosis is often needed.

Imaging Tests

Imaging helps locate the tumor, determine whether it has spread, and plan treatment. Common tests include CT scans, MRI scans, ultrasound, endoscopic ultrasound, and PET scans. Specialized neuroendocrine PET imaging, such as scans using gallium-68 dotatate or similar tracers, can identify tumors that express somatostatin receptors.

Biopsy and Pathology

A biopsy involves removing a small tissue sample and examining it under a microscope. Pathologists look at the tumor type, grade, differentiation, and markers that help confirm neuroendocrine origin. Ki-67, a marker of how quickly cells are dividing, may help classify the tumor and guide treatment.

Treatment Options for Neuroendocrine Tumors

Treatment for neuroendocrine tumors is not one-size-fits-all. A small, slow-growing rectal NET is not treated the same way as a metastatic pancreatic NET or a high-grade neuroendocrine carcinoma. The care team may include medical oncologists, surgeons, endocrinologists, gastroenterologists, pulmonologists, radiologists, nuclear medicine specialists, pathologists, dietitians, and nurses.

Active Surveillance

Some slow-growing NETs may not need immediate treatment. Active surveillance means the care team monitors the tumor with scheduled imaging, blood tests, urine tests, and follow-up visits. Treatment begins if the tumor grows, spreads, causes symptoms, or changes behavior. This approach can help avoid unnecessary side effects when a tumor is behaving politelyat least for now.

Surgery

Surgery is often the main treatment when a neuroendocrine tumor is localized and can be safely removed. It may offer the best chance for cure in early-stage disease. Depending on the tumor location, surgery may involve removing the tumor alone, part of an organ, nearby lymph nodes, or metastatic deposits.

Even when NETs have spread, surgery may still be used in selected cases to reduce tumor burden, prevent blockage, relieve symptoms, or address liver metastases. The decision depends on overall health, tumor biology, extent of disease, and expected benefit.

Somatostatin Analogs

Somatostatin analogs, such as octreotide and lanreotide, can help control symptoms caused by hormone secretion. They may also slow tumor growth in certain well-differentiated NETs. These medications are commonly given as injections and are especially useful for patients with carcinoid syndrome or somatostatin receptor-positive tumors.

Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy, or PRRT, is a targeted radiation treatment for certain NETs that have somatostatin receptors. The treatment attaches a radioactive particle to a molecule that binds to tumor receptors, delivering radiation more directly to cancer cells. Lutetium Lu 177 dotatate is one example used for somatostatin receptor-positive gastroenteropancreatic NETs in eligible patients.

Targeted Therapy

Targeted therapies interfere with specific pathways that cancer cells use to grow or form blood vessels. Drugs such as everolimus or sunitinib may be used in selected NETs, especially pancreatic NETs or advanced disease. These treatments are not magic erasers, but they can help slow progression and control disease in the right setting.

Chemotherapy

Chemotherapy may be recommended for high-grade neuroendocrine carcinomas, fast-growing tumors, or some pancreatic NETs. Treatment combinations vary based on tumor type and grade. High-grade cancers often need a more aggressive strategy because they behave differently from slow-growing well-differentiated NETs.

Radiation and Liver-Directed Treatments

Radiation therapy may help treat painful bone metastases, certain lung or high-grade tumors, or localized disease that cannot be removed surgically. Liver-directed treatments may be used when NETs spread to the liver. These may include embolization, radioembolization, ablation, or surgical approaches, depending on the number, size, and location of liver tumors.

Living With a Neuroendocrine Tumor

Living with a neuroendocrine tumor often means living with uncertainty. Some patients are treated and move into long-term monitoring. Others manage NET as a chronic cancer with ongoing scans, injections, lab tests, diet adjustments, and periodic treatment changes. The experience can feel like having a calendar full of appointments with a side order of “What does this lab value mean?”

Nutrition may become important, especially for patients with chronic diarrhea, flushing, pancreatic issues, bowel surgery, or carcinoid syndrome. Some people find that alcohol, spicy foods, large meals, or high-fat meals worsen symptoms. Others need help maintaining weight, correcting vitamin deficiencies, or managing blood sugar changes. A registered dietitian familiar with NETs can be a valuable part of the care team.

Emotional health also matters. NETs are rare, and rare diseases can feel lonely. Patients may have spent months or years being told their symptoms were stress, diet, hormones, asthma, or “probably nothing.” When a diagnosis finally arrives, it can bring relief, fear, anger, and a strange desire to become a part-time medical researcher overnight. Support groups, counseling, patient organizations, and clear communication with the care team can help reduce that isolation.

Experiences and Practical Lessons From the NET Journey

The experience of having a neuroendocrine tumor is often different from the cancer story many people expect. Some cancers arrive like thunder. NETs may arrive like a quiet email marked “low priority” that turns out to be very important. Many patients describe years of vague symptoms before diagnosis: flushing that looked like hot flashes, diarrhea blamed on food, wheezing treated like asthma, or abdominal pain explained away as stress. This does not mean every stomachache is a NET. It does mean persistent, unexplained symptoms deserve attention, especially when they keep returning like a bad sequel nobody asked for.

One common lesson is the importance of tracking symptoms. A simple notebook or phone note can help patients record flushing episodes, bowel changes, pain, weight changes, food triggers, blood sugar crashes, medications, and questions for the doctor. Patterns that seem random at home may become useful clues in the clinic. For example, diarrhea plus flushing plus wheezing may point a doctor toward hormone-related testing. Recurrent low blood sugar may lead to evaluation for insulin-producing tumors. Data may not be glamorous, but in rare disease care, it can be the quiet hero wearing sensible shoes.

Another experience many patients share is the need for specialized care. Because NETs are uncommon and complex, patients often benefit from evaluation by a team familiar with neuroendocrine tumors. A specialist can help interpret scans, determine whether the tumor is well-differentiated or high-grade, decide whether somatostatin receptor imaging is appropriate, and explain options such as PRRT, targeted therapy, liver-directed treatment, or clinical trials. A second opinion is not an insult to a doctor; it is a way to make sure the treatment map has all the roads on it.

Treatment experiences vary widely. Someone with a small appendiceal NET may have surgery and monitoring. A patient with metastatic small bowel NET may receive monthly somatostatin analog injections for years. A person with pancreatic NET may move through surgery, targeted therapy, chemotherapy, or PRRT depending on tumor behavior. Side effects can include fatigue, digestive changes, injection-site soreness, blood count changes, nausea, or appetite shifts. The practical strategy is to report symptoms early rather than waiting until they become dramatic. Cancer care teams have more tools when problems are small than when they have built a tiny empire.

Daily life with NET also includes emotional recalibration. Scan days can be stressful. Lab results can turn ordinary Tuesdays into suspense novels. Friends may not understand why a “slow-growing cancer” still feels frightening. Patients often learn to balance hope with realism, humor with seriousness, and planning with flexibility. Some people continue working, parenting, traveling, exercising, and doing ordinary life with adjustments. Others need more rest or support. There is no single correct way to live with a NET, but there is value in building a care circle: medical experts, family, friends, nutrition support, mental health support, and people who understand the zebra-striped weirdness of this diagnosis.

Perhaps the most useful lesson is this: neuroendocrine tumor care is a marathon with medical snacks, not a sprint. Questions are allowed. Notes are helpful. Follow-up matters. Symptoms deserve respect. And while NETs can be complicated, modern care offers more ways than ever to diagnose, monitor, treat, and live with these tumors.

Conclusion

Neuroendocrine tumors are rare, diverse cancers that begin in hormone-responsive neuroendocrine cells. They may develop in the gastrointestinal tract, pancreas, lungs, appendix, rectum, or other organs. Some grow slowly and quietly. Others produce hormones that cause flushing, diarrhea, wheezing, ulcers, blood sugar changes, or carcinoid syndrome. A smaller group behaves aggressively and needs urgent treatment.

The most important takeaway is that NETs require individualized care. Diagnosis often combines imaging, blood and urine tests, biopsy, pathology, and specialized scans. Treatment may include surgery, surveillance, somatostatin analogs, PRRT, targeted therapy, chemotherapy, radiation, liver-directed therapy, or symptom management. With the right team and a clear plan, many people with neuroendocrine tumors can manage the disease, reduce symptoms, and maintain quality of life.

Note: This article is for educational purposes only and is based on current information from reputable U.S. medical and cancer resources. It should not replace professional diagnosis, treatment, or personalized medical advice from a qualified healthcare provider.